This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

IMRIS Announces Addition Of Dr. Vipul Patel To SYMBIS™ Advisory Board

Stocks in this article: IM IMRS

World's most experienced robotic surgeon to consult on neurosurgical robot

MINNEAPOLIS, Sept. 19, 2013 /PRNewswire/ - Global intraoperative imaging company IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Vipul Patel, M.D., of Florida Hospital Celebration Health, has joined the SYMBIS™ Surgical System Advisory Board.  Dr. Patel is the internationally recognized leader in the field of robotic surgery, with experience performing over 6,000 robotic prostatectomies.

"Dr. Patel brings to the SYMBIS Advisory Board a wealth of experience in terms of surgeon training and the integration of robotics into the operating room," IMRIS CEO Jay D. Miller said.  "As we develop our training plans and work our way through the regulatory process, we look forward to Dr. Patel's contributions as a surgeon who has performed more robotic surgery than anyone else in the world."

"Robotics combined with intraoperative imaging will continue to transform minimally invasive surgery," Dr. Patel said. "High-field intraoperative imaging allows surgeons to identify tumors beyond what can be seen with the naked eye and helps surgeons avoid damage to vital nerves and vessels." The SYMBIS Surgical System will be the world's first MRI-compatible robot, allowing the integration of imaging with surgical robotics.

Dr. Patel is currently the medical director of the Global Robotics Institute and the urologic oncology program for the Florida Hospital Cancer Institute. As Editor Emeritus and Founding Editor of the Journal of Robotic Surgery, Dr. Patel also brings a significant amount of insight to the SYMBIS Advisory Board in terms of robotic surgery research, procedure development and continuing education. Although Dr. Patel's specialty is urology, there are many aspects of robotic surgery that transfer across surgical specialties.

The SYMBIS Advisory Board, established in May, provides guidance in the clinical study and surgeon training on the SYMBIS Surgical System. Dr. Patel joins three other board members: Garnette Sutherland, M.D., FRCS(C) of Foothills Medical Center at the University of Calgary, Calgary, Alberta; David Roberts, M.D., FAANS, of the Geisel School of Medicine at Dartmouth, Hanover and Lebanon, NH; and Melvin Field, M.D., of Orlando Neurosurgery in Winter Park, and Florida Hospital in Orlando, FL.

The SYMBIS Surgical System is currently under development and not available for sale.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs